GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exicure Inc (STU:2H0A) » Definitions » Price-to-Funds-From-Operations

Exicure (STU:2H0A) Price-to-Funds-From-Operations : (As of Jun. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Exicure Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Exicure (STU:2H0A) Business Description

Industry
Traded in Other Exchanges
Address
2430 N. Halsted Street, Suite 410, Chicago, IL, USA, 60614
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.